Literature DB >> 8911280

Expression of VEGF receptors in arteries after endothelial injury and lack of increased endothelial regrowth in response to VEGF.

V Lindner1, M A Reidy.   

Abstract

Vascular endothelial growth factor (VEGF) is an endothelial cell-specific factor with angiogenic effects in vivo and mitogenic effects in vitro. Administration of VEGF has been reported to stimulate endothelial growth in denuded arteries and new blood vessel formation in models of induced tissue ischemia. In the present study, expression of VEGF and its receptors flk-l and flt-l was determined in injured aortas and carotid arteries of rats and mice. Neither VEGF nor flk-l mRNA was detectable in vascular cells. mRNA levels for flt-l were dramatically upregulated at the leading edge of a growing endothelial monolayer in vivo; however, these cells did not demonstrate increased replication after VEGF infusion. Furthermore, all doses and treatment protocols of VEGF failed to promote reendothelialization in denuded arteries. At sites of flt-l expression, VEGF increased permeability. These areas revealed a loss of endothelial contacts at the ultrastructural level. These findings suggest that VEGF is not a direct mitogen for large-vessel endothelium in vivo and that VEGF may play a role in abolishing contact inhibition, which may be a prerequisite for endothelial proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911280     DOI: 10.1161/01.atv.16.11.1399

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

Review 1.  Clinical applications of vascular gene therapy.

Authors:  J Rutanen; T T Rissanen; A Kivelä; I Vajanto; S Ylä-Herttuala
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

2.  The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A.

Authors:  Raj Kishore; Gangjian Qin; Corinne Luedemann; Evelyn Bord; Allison Hanley; Marcy Silver; Mary Gavin; Young-sup Yoon; David Goukassian; David Goukassain; Douglas W Losordo
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

3.  Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.

Authors:  Ting He; Nataliya Smith; Debra Saunders; Benjamin P Pittman; Megan Lerner; Stanley Lightfoot; Robert Silasi-Mansat; Florea Lupu; Rheal A Towner
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-07-10

Review 4.  Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury.

Authors:  Austin I McDonald; M Luisa Iruela-Arispe
Journal:  Vascul Pharmacol       Date:  2015-06-18       Impact factor: 5.773

5.  Tgfβ1-Cthrc1 Signaling Plays an Important Role in the Short-Term Reparative Response to Heart Valve Endothelial Injury.

Authors:  Emily M Nordquist; Punashi Dutta; Karthik M Kodigepalli; Carol Mattern; Michael R McDermott; Aaron J Trask; Stephanie LaHaye; Volkhard Lindner; Joy Lincoln
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-14       Impact factor: 8.311

6.  Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas.

Authors:  Ting He; Nataliya Smith; Debra Saunders; Sabrina Doblas; Yasuko Watanabe; Jessica Hoyle; Robert Silasi-Mansat; Florea Lupu; Megan Lerner; Daniel J Brackett; Rheal A Towner
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

Review 7.  5-methoxytryptophan: an arsenal against vascular injury and inflammation.

Authors:  Kenneth K Wu; Cheng-Chin Kuo; Shaw-Fang Yet; Chii-Ming Lee; Jun-Yang Liou
Journal:  J Biomed Sci       Date:  2020-07-07       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.